Form 8-K - Current report:
SEC Accession No. 0001104659-20-131313
Filing Date
2020-12-02
Accepted
2020-12-02 07:00:35
Documents
14
Period of Report
2020-11-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2037443d1_8k.htm   iXBRL 8-K 29059
2 EXHIBIT 99.1 tm2037443d1_ex99-1.htm EX-99.1 7987
3 GRAPHIC tm2037443d1_ex99-1img001.jpg GRAPHIC 6445
  Complete submission text file 0001104659-20-131313.txt   222876

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA fold-20201130.xsd EX-101.SCH 3216
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE fold-20201130_lab.xml EX-101.LAB 34591
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fold-20201130_pre.xml EX-101.PRE 22730
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2037443d1_8k_htm.xml XML 3483
Mailing Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512 (609) 662-2000
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33497 | Film No.: 201362384
SIC: 2834 Pharmaceutical Preparations